BioSenic S.A. (0R55.L)

EUR 0.01

(-14.29%)

Total Assets Summary of BioSenic S.A.

BioSenic S.A.'s latest annual total assets in 2023 was 9.55 Million EUR , down -67.4% from previous year.
BioSenic S.A.'s latest quarterly total assets in 2024 Q2 was 9.39 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported annual total assets of 29.32 Million EUR in 2022, up 48.31% from previous year.
BioSenic S.A. reported annual total assets of 19.77 Million EUR in 2021, down -20.39% from previous year.
BioSenic S.A. reported quarterly total assets of 9.39 Million EUR for 2024 Q1, down -1.71% from previous quarter.
BioSenic S.A. reported quarterly total assets of 9.55 Million EUR for 2023 Q3, down -8.02% from previous quarter.

Annual Total Assets Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Total Assets of BioSenic S.A. (2023 - 2011)

Year	Total Assets	Total Assets Growth
2023	9.55 Million EUR	-67.4%
2022	29.32 Million EUR	48.31%
2021	19.77 Million EUR	-20.39%
2020	24.83 Million EUR	10.91%
2019	22.39 Million EUR	-13.05%
2018	25.75 Million EUR	2.3%
2017	25.17 Million EUR	-34.76%
2016	38.58 Million EUR	-23.42%
2015	50.38 Million EUR	108.18%
2014	24.2 Million EUR	88.92%
2013	12.81 Million EUR	-11.15%
2012	14.41 Million EUR	-4.22%
2011	15.05 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	9.39 Million EUR	0.0%
2024 Q1	9.39 Million EUR	-1.71%
2023 Q3	9.55 Million EUR	-8.02%
2023 Q4	9.55 Million EUR	0.0%
2023 Q1	10.39 Million EUR	-64.56%
2023 Q2	10.39 Million EUR	0.0%
2023 FY	9.55 Million EUR	-67.4%
2022 Q3	29.32 Million EUR	149.95%
2022 FY	29.32 Million EUR	48.31%
2022 Q4	29.32 Million EUR	0.0%
2022 Q2	11.73 Million EUR	0.0%
2021 Q2	14.32 Million EUR	0.0%
2021 Q4	19.77 Million EUR	0.0%
2021 FY	19.77 Million EUR	-20.39%
2020 Q2	22.64 Million EUR	0.0%
2020 FY	24.83 Million EUR	10.91%
2020 Q4	24.83 Million EUR	0.0%
2019 FY	22.39 Million EUR	-13.05%
2019 Q2	27.93 Million EUR	0.0%
2019 Q4	22.39 Million EUR	0.0%
2018 FY	25.75 Million EUR	2.3%
2018 Q4	25.75 Million EUR	0.0%
2018 Q2	24.43 Million EUR	0.0%
2017 FY	25.17 Million EUR	-34.76%
2017 Q4	25.17 Million EUR	0.0%
2017 Q2	29.84 Million EUR	0.0%
2016 Q4	38.58 Million EUR	0.0%
2016 Q2	43.38 Million EUR	0.0%
2016 FY	38.58 Million EUR	-23.42%
2015 Q2	51.3 Million EUR	0.0%
2015 FY	50.38 Million EUR	108.18%
2015 Q4	50.38 Million EUR	0.0%
2014 FY	24.2 Million EUR	88.92%
2014 Q4	24.2 Million EUR	86.59%
2014 Q3	12.97 Million EUR	0.0%
2013 Q4	12.81 Million EUR	0.0%
2013 FY	12.81 Million EUR	-11.15%
2012 FY	14.41 Million EUR	-4.22%
2011 FY	15.05 Million EUR	0.0%

Peer Total Assets Comparison of BioSenic S.A.

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	98.38%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	98.805%
Vetoquinol SA	692.23 Million EUR	98.619%
Valneva SE	469.39 Million EUR	97.964%
AB Science S.A.	25.49 Million EUR	62.512%
Nanobiotix S.A.	93.89 Million EUR	89.82%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	81.369%
Vivoryon Therapeutics N.V.	30.82 Million EUR	68.993%
ABIVAX Société Anonyme	327.06 Million EUR	97.077%
Formycon AG	890.36 Million EUR	98.926%